This is a non-core endpoint: only basic statistics are computed.
Mature T/NK-cell lymphomas, hilmo
CD2_TNK_LYMPHOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
487 |
4. Check minimum number of eventsNone |
487 |
5. Include endpointsNone |
487 |
6. Filter based on genotype QC (FinnGen only) |
467 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C81-C96
- Name in latin
- Lymphomata T-cellularia peripherica et cutanea
Similar endpoints
↥List of similar endpoints to
Mature T/NK-cell lymphomas, hilmo
based on the number of shared cases.
Similar with more cases:
- Non-Hodgkin lymphoma, all, including Hilmo
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 467 | 171 | 296 |
| Unadjusted period prevalence (%) | 0.11 | 0.06 | 0.14 |
| Median age at first event (years) | 66.39 | 66.08 | 66.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 487
- Matched controls
- 4870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
31.9
302.4
231
134
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
251.6
219
*
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
146.4
133
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.8
138.5
193
278
L03AA02
ATC
filgrastim; parenteral
19.7
131.6
110
71
XW000
NOMESCO Finland
Bone marrow biopsy
12.0
104.3
119
128
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
11.1
93.6
112
128
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
+∞
88.3
82
*
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
+∞
83.8
78
*
9700/3-C44.9
ICD-O-3
Mycosis fungoides of skin, NOS
+∞
81.6
76
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
30.2
80.1
54
20
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
13.7
77.5
77
66
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
46.1
77.1
46
11
WW500
NOMESCO Finland
Blood transfusion
9.8
73.0
93
114
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.5
70.7
103
149
JN4BD
NOMESCO Finland
Extensive body CT
6.1
70.3
156
349
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
39.2
69.2
43
12
PJA10
NOMESCO Finland
Exploration of lymph nodes
20.1
68.2
54
30
L03AA13
ATC
pegfilgrastim; parenteral
9.6
66.1
85
105
L30.9
ICD-10 Finland
Dermatitis, unspecified
5.1
64.2
191
547
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
21.7
64.2
49
25
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
+∞
57.4
54
*
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
+∞
57.4
54
*
D07AB08
ATC
desonide; topical
5.5
54.6
129
300
JN6AD
NOMESCO Finland
CT of torso and neck
16.8
53.5
46
30
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.2
50.6
60
66
D05BB02
ATC
acitretin; oral
12.3
48.3
50
45
D07AD01
ATC
clobetasol; topical
4.3
45.2
151
459
JN4AD
NOMESCO Finland
Body CT examination
5.0
45.0
117
292
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.1
44.4
86
165
C10AB05
ATC
fenofibrate; oral
12.6
43.5
44
38
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
14.5
42.1
39
29
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
41.5
130
374
E0000UV, ,
ATC
3.5
41.4
278
1332
R50.9
ICD-10 Finland
Fever, unspecified
4.1
40.3
142
445
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
+∞
39.1
37
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
13.2
38.8
38
31
TQW80
NOMESCO Finland
Local dermatologic skincare
9.9
38.3
46
51
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.9
38.2
75
145
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
+∞
38.0
36
*
H02AB06
ATC
prednisolone; systemic
3.5
38.0
323
1757
A03FA01
ATC
metoclopramide; systemic, rectal
3.4
34.6
174
682
D07AC01
ATC
betamethasone; topical
3.2
34.5
249
1209
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.4
33.5
36
34
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
+∞
32.7
31
*
L26
ICD-10 Finland
Exfoliative dermatitis
170.8
31.1
32
*
127
Kela drug reimbursment
Transplant complication
12.7
31.0
31
26
M04AA01
ATC
allopurinol; systemic
3.5
30.6
135
483
E000001, ,
ATC
3.3
30.2
147
559
A04AA01
ATC
ondansetron; systemic, rectal
4.5
30.0
83
214
WW300
NOMESCO Finland
Transfer of autologic stem cells
52.0
28.8
34
7
9700/3-C44.5
ICD-O-3
Mycosis fungoides of skin of trunk
+∞
28.4
27
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
37.6
27.8
35
10
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.8
27.5
53
100
D07AC13
ATC
mometasone; topical
2.9
27.4
195
914
C84.1
ICD-10 Finland
Sézary disease
+∞
27.3
26
*
J05AB11
ATC
valaciclovir; oral
3.4
26.8
115
402
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
55.0
26.5
31
6
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
25.8
26.1
36
15
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
9.9
25.5
30
32
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
32.1
25.3
33
11
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
25.2
24
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
36.7
24.6
31
9
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.6
24.1
29
32
WW409
NOMESCO Finland
Other aferesis
44.0
23.9
29
7
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
+∞
23.1
22
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
22.0
21
*
D02AE01
ATC
carbamide; topical
4.3
21.7
61
158
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.6
21.4
31
43
XQ848
NOMESCO Finland
Dermatological photography
6.3
21.2
37
63
A04AA02
ATC
granisetron; systemic, transdermal
4.2
21.2
61
161
H02AB09
ATC
hydrocortisone; systemic
7.5
21.0
31
44
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
37.5
20.0
25
7
E000002, ,
ATC
3.4
20.0
79
259
1XX25, ,
NOMESCO Finland
+∞
19.9
19
*
L04AD01
ATC
ciclosporin; systemic
8.5
19.8
26
32
H02AB07
ATC
prednisone; oral
3.0
19.7
104
406
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
19.6
58
156
134
Kela drug reimbursment
General erythroderma
36.0
19.1
24
7
E000006, ,
ATC
4.1
18.9
55
146
E000003, ,
ATC
5.0
18.6
42
91
ZX120
NOMESCO Finland
Intravenous
3.2
18.3
80
279
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
18.2
282
1812
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.7
17.9
34
63
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
17.8
95
371
WW402
NOMESCO Finland
Leucoferesis
186.5
17.6
18
*
ZX196, ,
NOMESCO Finland
+∞
16.8
16
*
L03AA14
ATC
lipegfilgrastim; parenteral
7.6
16.7
24
33
Z51.5
ICD-10 Finland
Palliative care
3.1
16.0
74
266
L04AX03
ATC
methotrexate; systemic
3.2
15.9
68
233
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
+∞
15.7
15
*
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
15.6
171
936
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.7
15.5
37
84
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.8
15.4
24
15
L01AA02
ATC
chlorambucil; oral
29.7
15.3
20
7
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
11.8
15.0
27
24
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.1
14.9
32
66
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
21.9
14.8
21
10
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
14.7
14
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
14.5
120
579
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
43.9
14.2
17
*
D02AX
ATC
Other emollients and protectives
5.3
14.0
29
58
L40.0
ICD-10 Finland
Psoriasis vulgaris
4.6
13.8
34
79
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
13.6
13
*
9700/3-C44.7
ICD-O-3
Mycosis fungoides of skin of lower limb and hip
+∞
13.6
13
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
6.5
13.4
22
35
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.7
13.3
80
331
D07AA02
ATC
hydrocortisone; topical
2.6
13.2
86
370
TK800
NOMESCO Finland
Hemodialysis
5.7
13.2
25
46
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.7
13.0
76
309
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.8
13.0
30
66
J01MA12
ATC
levofloxacin; systemic
2.3
12.9
127
658
J02AC01
ATC
fluconazole; systemic
2.1
12.2
169
998
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.6
12.0
80
348
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.9
11.9
59
220
L20.0
ICD-10 Finland
Besnier prurigo
3.7
11.8
38
108
A07AA02
ATC
nystatin; oral
3.4
11.8
44
138
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
11.5
11
*
L41.8
ICD-10 Finland
Other parapsoriasis
122.8
11.5
12
*
D07XC01
ATC
betamethasone; topical
2.5
11.3
78
344
A02BC02
ATC
pantoprazole; systemic
2.0
11.1
347
2681
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
12.3
10.9
19
16
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.1
10.7
30
77
A41.9
ICD-10 Finland
Sepsis, unspecified
3.8
10.7
33
91
H03AA01
ATC
levothyroxine sodium; systemic
2.1
10.7
120
650
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
61.4
10.7
12
*
N02AA05
ATC
oxycodone; systemic
2.1
10.6
121
659
9702/3-C42.1
ICD-O-3
Mature T-cell lymphoma, NOS, of bone marrow
+∞
10.5
10
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
12.4
10.4
18
15
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.9
10.4
53
200
B72
ICPC
Hodgkin Lymphoma
33.3
10.4
13
*
TGC00
NOMESCO Finland
Bronchial lavation
4.0
10.3
29
75
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.9
9.9
48
176
R06AE07
ATC
cetirizine; oral
1.9
9.9
193
1263
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
56.1
9.7
11
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
9.5
182
1181
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
9.5
70
318
L41.4
ICD-10 Finland
Large plaque parapsoriasis
101.9
9.4
10
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
9.4
9
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
9.4
9
*
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
+∞
9.4
9
*
9717/3-C17.9
ICD-O-3
Intestinal T-cell lymphoma of small intestine, NOS
+∞
9.4
9
*
E000007, ,
ATC
3.4
9.4
35
110
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
9.2
128
747
WW200
NOMESCO Finland
Immunization
4.7
9.1
21
46
J05AB01
ATC
aciclovir; systemic
2.0
9.1
113
633
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
37.4
9.1
11
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
24.5
8.9
12
5
A05AA02
ATC
ursodeoxycholic acid; oral
8.2
8.9
19
24
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
8.9
32
98
S18
ICPC
Laceration/cut
1.8
8.9
240
1718
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.9
8.9
18
21
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
6.8
8.7
21
32
ZXE00
NOMESCO Finland
One hour or less
1.8
8.7
193
1302
JFB00
NOMESCO Finland
Partial resection of small intestine
7.1
8.6
20
29
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
16.6
8.6
13
8
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.3
8.5
22
53
J01DB01
ATC
cefalexin; oral
2.0
8.5
393
3288
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
20.5
8.5
12
6
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.4
8.5
31
96
9700/3-C44.6
ICD-O-3
Mycosis fungoides of skin of upper limb and shoulder
+∞
8.4
8
*
C84
ICD-10 Finland
Mature T/NK-cell lymphomas
+∞
8.4
8
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.3
8.3
21
50
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.8
8.2
13
9
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.7
8.2
18
24
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
8.2
60
271
212
Kela drug reimbursment
Gout
4.7
8.2
19
42
L30.3
ICD-10 Finland
Infective dermatitis
3.8
8.1
25
69
D69.5
ICD-10 Finland
Secondary thrombocytopenia
34.0
8.1
10
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
8.0
40
149
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
8.0
71
348
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.7
8.0
45
179
L04AA06
ATC
mycophenolic acid; systemic
6.8
8.0
19
29
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
8.0
55
242
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.6
7.9
48
198
WZC00
NOMESCO Finland
Treatment plan or consultation
1.8
7.9
173
1156
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.1
7.8
18
26
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
11.0
7.8
14
13
WZC30
NOMESCO Finland
Teaching
2.0
7.8
89
482
RS340, ,
NOMESCO Finland
45.7
7.7
9
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
45.7
7.7
9
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.5
7.7
52
226
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.1
7.7
21
53
H02AB02
ATC
dexamethasone; systemic
2.2
7.6
68
334
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
7.6
119
717
D70.89
ICD-10 Finland
Neutropenic splenomegaly
7.3
7.5
17
24
L04AA01
ATC
[U] ciclosporin
7.8
7.4
16
21
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
81.3
7.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
4.1
7.4
20
50
L01CB01
ATC
etoposide; systemic
11.1
7.3
13
12
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
7.3
7
*
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
+∞
7.3
7
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
+∞
7.3
7
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
7.3
7
*
C84.2
ICD-10 Finland
T-zone lymphoma
+∞
7.3
7
*
9701/3-C44.9
ICD-O-3
Sezary syndrome of skin, NOS
+∞
7.3
7
*
C84.3
ICD-10 Finland
Lymphoepithelioid lymphoma
+∞
7.3
7
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
30.5
7.2
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
7.2
149
976
ZXC50
NOMESCO Finland
Cryotherapy
3.3
7.1
26
81
J01MA14
ATC
moxifloxacin; systemic
2.3
7.1
53
242
ZX112
NOMESCO Finland
Subcutaneous
4.0
7.0
20
52
WF002
NOMESCO Finland
Radical radiotherapy
2.5
7.0
43
179
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.5
6.8
23
68
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
40.6
6.8
8
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
40.6
6.8
8
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.8
6.7
33
122
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
22.9
6.7
9
*
FM1FN
NOMESCO Finland
Heart function isotope examination
22.9
6.7
9
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
6.6
6.7
16
25
D11AH01
ATC
tacrolimus; topical
12.5
6.6
11
9
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
8.9
6.6
13
15
1XC12, ,
NOMESCO Finland
70.7
6.4
7
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
70.7
6.4
7
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
70.7
6.4
7
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
14.5
6.4
10
7
ZX108
NOMESCO Finland
Inhalation
8.3
6.4
13
16
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.1
6.3
26
87
N05CF01
ATC
zopiclone; oral
1.7
6.3
165
1145
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
18.3
6.3
9
5
GD1AD
NOMESCO Finland
Thorax CT examination
2.6
6.3
37
151
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
6.3
58
289
N05BB01
ATC
hydroxyzine; systemic
2.7
6.3
34
133
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
+∞
6.3
6
*
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
+∞
6.3
6
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
6.3
6
*
9705/3-C42.1
ICD-O-3
Angioimmunoblastic T-cell lymphoma of bone marrow
+∞
6.3
6
*
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
27.0
6.2
8
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
27.0
6.2
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.4
6.2
22
67
Z2446
NOMESCO Finland
Social worker
2.5
6.2
38
158
H26.3
ICD-10 Finland
Drug-induced cataract
10.2
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
90
29
37.84
141.30
1.6
1.3
—
—
—
0
0
108
66
20.74
132.68
5.2
3.5
29322.14
3128.38
u/ml
—
28
8
122
7
231.66
122.88
1.9
1.1
—
—
—
0
0
106
81
16.45
115.49
9.7
6.1
438.90
126.50
iu/ml
—
21
10
73
23
37.16
114.80
2.3
2.2
—
—
—
0
0
68
23
34.20
104.47
1.9
2.0
40.63
34.51
%
0.66
68
23
70
29
28.02
100.40
3.5
2.0
562.63
542.46
e6/l
0.06
54
24
69
74
10.70
59.46
1.6
1.4
—
—
—
0
0
171
524
4.49
51.31
5.4
2.6
1.87
1.78
%
0.50
162
478
42
26
17.58
50.09
4.5
2.8
38.25
42.33
%
0.40
28
18
351
1805
4.38
49.96
13.8
5.7
56.34
58.18
%
1.80
346
1689
59
66
10.03
49.09
1.6
1.4
172.45
97.77
u/ml
0.48
11
13
69
105
7.49
44.57
3.9
1.6
—
—
—
0
0
58
73
8.88
43.98
3.8
1.5
—
—
—
0
0
58
73
8.88
43.98
3.8
1.5
—
—
—
0
0
69
109
7.21
43.04
3.7
1.6
—
—
—
0
0
134
391
4.35
42.06
5.0
2.7
73.17
68.50
e9/l
0.70
111
311
56
73
8.54
41.22
1.5
1.2
—
—
—
0
0
47
49
10.51
40.99
3.5
1.6
—
—
—
0
0
57
78
8.14
40.28
3.6
1.7
—
—
—
0
0
44
46
10.42
38.25
3.6
1.6
—
—
—
0
0
372
2242
3.79
36.38
27.5
9.4
3.79
4.22
e9/l
3.37
348
1963
172
675
3.39
34.10
10.2
3.5
0.79
0.82
mmol/l
2.51
167
636
224
1053
3.09
32.35
7.0
2.9
1613.47
8268.79
umol/l
2.60
215
911
102
293
4.14
32.07
3.2
1.6
—
—
—
0
0
48
71
7.39
31.56
1.4
1.2
351.80
264.11
u/ml
0.64
30
37
142
534
3.34
29.66
11.6
5.9
1.06
1.03
mmol/l
0.74
137
493
59
123
5.32
27.45
2.2
1.2
—
—
—
0
0
32
34
10.00
27.35
1.6
1.4
—
—
—
0
0
35
44
8.49
26.33
4.3
1.6
—
—
—
0
0
35
44
8.49
26.33
4.3
1.6
—
—
—
0
0
35
44
8.49
26.33
4.3
1.6
—
—
—
0
0
44
78
6.10
24.26
2.3
1.6
—
—
—
0
0
73
203
4.05
23.67
1.7
1.8
1.67
1.55
g/l
0.38
65
178
34
48
7.54
23.18
2.6
1.4
—
—
—
0
0
34
48
7.54
23.18
2.6
1.4
—
—
—
0
0
38
61
6.67
23.07
2.0
1.7
—
—
—
0
0
295
1820
2.57
22.55
12.4
4.9
32.94
35.09
g/l
7.71
286
1695
38
65
6.26
21.68
1.9
1.6
—
—
—
0
0
50
117
4.65
20.20
2.2
1.5
—
—
—
0
0
154
732
2.61
19.98
3.9
1.8
—
—
—
0
0
43
96
4.82
18.36
3.0
1.3
—
—
—
0
0
316
2138
2.36
17.92
19.1
6.8
11.05
11.79
umol/l
0.47
310
2027
57
163
3.83
17.64
1.3
2.1
43.68
39.19
u/l
0.68
50
144
44
105
4.51
17.32
1.4
2.0
13.01
12.68
mg/l
0.07
36
97
65
206
3.49
17.27
1.7
1.2
2249.28
221.87
u/ml
0.69
58
187
263
1687
2.22
16.42
18.9
10.0
0.00
0.00
e9/l
0.47
226
1384
29
50
6.10
16.37
2.2
1.7
—
—
—
0
0
32
61
5.54
16.30
2.6
1.7
—
—
—
0
0
28
47
6.26
16.22
4.1
2.4
—
—
—
0
0
34
70
5.15
15.92
2.6
1.6
—
—
—
0
0
223
1355
2.19
15.77
8.2
3.6
2.34
2.35
mmol/l
0.50
214
1189
26
20
13.66
15.35
5.0
1.6
—
—
—
0
0
110
501
2.54
15.14
2.9
1.8
—
—
—
0
0
25
19
13.80
14.85
5.1
1.7
—
—
—
0
0
25
19
13.80
14.85
5.1
1.7
—
—
—
0
0
136
690
2.35
14.73
1.6
1.4
2.54
2.71
g/l
0.29
105
399
26
45
6.05
14.61
1.7
1.7
—
—
—
0
0
109
506
2.49
14.35
3.2
1.8
—
—
—
0
0
51
158
3.49
13.97
2.6
2.9
—
—
—
0
0
97
435
2.54
13.69
4.8
3.6
—
—
—
0
0
290
2028
2.06
13.38
16.6
7.1
1.22
1.21
mmol/l
0.48
251
1718
27
53
5.33
13.31
3.9
1.3
—
—
—
0
0
25
25
10.48
13.13
5.2
1.6
—
—
—
0
0
25
25
10.48
13.13
5.2
1.6
—
—
—
0
0
372
2874
2.25
12.97
7.2
4.2
16.36
13.20
mm/h
2.70
363
2620
27
55
5.14
12.78
3.9
1.3
—
—
—
0
0
27
55
5.14
12.78
3.9
1.3
—
—
—
0
0
27
55
5.14
12.78
3.8
1.3
—
—
—
0
0
27
55
5.14
12.78
3.8
1.3
—
—
—
0
0
27
56
5.05
12.52
3.8
1.3
—
—
—
0
0
101
483
2.38
12.31
9.4
3.0
6.11
9.49
umol/l
1.77
94
429
31
74
4.41
12.17
5.3
3.5
53.68
59.04
%
1.34
31
74
23
24
10.00
11.86
2.4
1.1
—
—
—
0
0
23
24
10.00
11.86
2.3
1.1
—
—
—
0
0
27
59
4.79
11.79
2.7
2.0
34.59
33.53
pg
0.88
27
59
16
8
20.62
11.20
2.1
1.6
—
—
—
0
0
45
152
3.16
10.72
1.6
2.8
0.47
1.14
g/l
0.66
40
135
260
1842
1.88
10.56
6.2
2.7
—
—
—
0
0
20
21
9.88
10.35
2.6
1.0
—
—
—
0
0
20
21
9.88
10.35
2.6
1.0
—
—
—
0
0
261
1859
1.87
10.35
14.1
6.5
1.21
1.21
mmol/l
0.20
254
1681
15
8
19.29
10.32
2.1
1.4
—
—
—
0
0
84
399
2.34
10.30
5.9
3.7
1.17
1.99
mmol/l
1.00
74
325
76
354
2.36
9.72
3.1
1.9
368.59
384.03
nmol/l
0.24
71
326
47
177
2.83
9.26
1.5
2.4
—
—
—
0
0
48
183
2.80
9.25
4.9
1.7
—
—
—
0
0
135
803
1.94
9.13
8.6
3.3
2.48
2.46
mmol/l
1.94
127
709
139
835
1.93
9.13
2.5
1.7
1.82
1.30
mg/l
1.56
121
651
20
29
7.14
8.63
7.7
4.3
—
—
—
0
0
15
13
11.86
8.62
7.8
1.2
—
—
—
0
0
33
106
3.27
8.54
1.5
1.3
—
—
—
0
0
39
139
2.96
8.49
1.5
1.7
—
231.43
—
0
7
14
11
13.06
8.42
1.8
1.4
—
—
—
0
0
156
1000
1.82
8.24
6.3
2.5
—
—
—
0
0
39
142
2.90
8.18
1.5
4.3
55.49
33.74
mg/l
1.08
29
112
39
142
2.90
8.18
1.5
4.2
73.55
109.36
mg/l
0.32
30
109
273
2064
1.73
8.06
16.9
16.4
1.27
1.33
inr
0.47
72
588
11
5
22.45
8.04
2.6
1.4
—
—
—
0
0
59
271
2.34
7.75
2.3
1.6
—
—
—
0
0
306
2416
1.72
7.47
9.0
5.2
6.65
6.81
mmol/l
0.83
295
2283
41
162
2.67
7.39
2.4
1.6
—
—
—
0
0
11
8
14.03
6.92
1.1
1.0
—
—
—
0
0
210
1537
1.64
6.56
4.2
3.3
—
—
—
0
0
18
34
5.45
6.52
1.2
1.1
—
—
—
0
0
30
111
2.81
6.13
1.8
1.2
—
—
—
0
0
14
21
6.83
6.07
1.4
1.2
—
—
—
0
0
30
112
2.79
6.04
1.8
1.2
—
—
—
0
0
9
6
15.24
5.92
1.4
1.3
—
—
—
0
0
71
392
1.95
5.81
3.0
2.4
0.20
0.20
g/l
0.44
66
363
59
305
2.06
5.80
3.6
4.1
100.04
85.97
ng/l
0.38
54
276
21
65
3.33
5.79
1.0
1.0
—
—
—
0
0
56
284
2.10
5.79
7.4
3.5
2.08
1.92
mmol/l
0.12
47
210
179
1291
1.61
5.75
4.2
3.3
15.11
120.84
e6/l
1.42
141
1007
14
23
6.23
5.73
1.3
1.3
—
—
—
0
0
204
1522
1.59
5.67
2.4
2.2
75.57
76.56
nmol/l
0.19
187
1331
24
83
2.99
5.54
1.5
1.2
—
—
—
0
0
42
193
2.29
5.53
8.5
3.9
25.00
25.04
mmol/l
0.02
42
180
149
1036
1.63
5.52
2.6
2.1
3.33
3.16
mg/l
0.30
139
884
16
33
4.98
5.47
1.4
1.7
—
—
—
0
0
26
96
2.80
5.35
1.5
1.2
—
2.54
—
0
5
14
26
5.51
5.26
1.3
1.4
—
—
—
0
0
203
1534
1.55
5.22
3.8
2.7
627.79
160.70
ug/l
3.41
189
1390
58
311
1.98
5.16
7.3
3.4
5.04
5.15
kpa
0.57
58
295
123
828
1.65
5.13
1.8
1.7
996.90
1200.19
nmol/l
1.70
101
614
14
27
5.31
5.11
1.2
1.5
—
—
—
0
0
95
599
1.73
5.06
2.8
2.4
22.89
22.41
%
0.10
82
520
29
117
2.57
5.06
1.4
1.6
—
—
—
0
0
170
1249
1.55
4.89
7.1
3.3
35.26
33.71
u/l
0.28
163
1190
314
2633
1.54
4.88
6.0
4.6
8.20
2063.37
e6/l
—
5
52
97
626
1.69
4.73
2.7
2.4
2.13
2.27
g/l
1.26
91
579
35
160
2.28
4.68
1.7
1.3
—
—
—
0
0
12
22
5.56
4.63
1.3
1.9
—
—
—
0
0
171
1273
1.53
4.58
3.5
2.5
69.56
59.93
u/l
0.20
160
1180
28
117
2.48
4.56
1.6
2.1
—
—
—
0
0
13
27
4.92
4.52
1.2
1.5
—
—
—
0
0
103
685
1.64
4.46
2.8
2.5
11.91
12.49
umol/l
0.31
96
642
120
835
1.58
4.31
4.5
3.9
161.17
268.71
ng/l
0.50
100
695
158
1172
1.52
4.25
4.1
3.3
0.21
0.54
e6/l
2.60
126
892
24
98
2.52
4.11
1.9
1.5
—
—
—
0
0
14
36
3.97
4.02
2.6
1.8
—
—
—
0
0
11
22
5.09
4.02
2.4
2.0
—
—
—
0
0
7
7
10.12
4.02
1.3
1.0
—
—
—
0
0
102
694
1.59
4.00
3.5
3.0
4.38
1.83
e6/l
0.44
64
390
9
14
6.53
4.00
3.0
6.1
—
—
—
0
0
11
23
4.87
3.89
2.4
2.0
—
—
—
0
0
77
493
1.67
3.85
9.1
8.8
4.73
5.10
kpa
2.89
71
476
12
28
4.37
3.84
2.3
1.9
—
—
—
0
0
77
494
1.66
3.82
9.2
8.8
11.35
11.70
kpa
0.31
71
480
186
1452
1.45
3.79
4.8
3.8
117.13
155.31
e6/l
0.14
146
1065
6
5
12.12
3.77
1.0
1.2
—
—
—
0
0
6
5
12.12
3.77
1.0
1.0
—
—
—
0
0
11
24
4.66
3.76
1.5
1.2
—
—
—
0
0
10
20
5.08
3.70
2.1
1.1
—
—
—
0
0
10
20
5.08
3.70
1.2
1.1
—
—
—
0
0
177
1377
1.45
3.65
3.2
3.2
2512.87
1480.32
ng/l
0.60
160
1190
23
98
2.41
3.63
1.2
1.2
—
—
—
0
0
76
494
1.64
3.58
9.1
8.8
-0.24
1.21
mmol/l
1.52
55
404
20
81
2.53
3.51
1.4
1.4
—
—
—
0
0
20
81
2.53
3.51
1.4
1.4
—
—
—
0
0
9
18
5.07
3.38
1.8
1.4
—
—
—
0
0
8
14
5.79
3.35
1.3
1.1
—
—
—
0
0
8
14
5.79
3.35
1.4
1.4
—
—
—
0
0
11
28
3.99
3.30
1.5
1.2
—
82.00
—
0
5
21
90
2.39
3.29
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
29
143
2.09
3.28
2.7
2.8
0.34
0.34
u/ml
0.02
17
76
120
884
1.47
3.23
3.5
2.7
4.28
4.22
e6/l
0.03
109
799
17
67
2.59
3.16
2.1
1.4
25.15
28.44
iu/l
0.16
17
56
155
1225
1.39
2.80
2.2
2.2
128.63
292.95
u/l
1.88
150
1149
5
6
8.40
2.75
3.2
1.7
38.60
39.00
u/l
—
5
6
12
43
2.84
2.66
1.3
1.3
—
—
—
0
0
12
43
2.84
2.66
1.2
2.7
—
—
—
0
0
7
15
4.72
2.60
1.9
4.2
213.00
219.87
u/l
—
7
15
44
271
1.69
2.57
2.2
1.4
—
—
—
0
0
205
1714
1.34
2.54
2.2
2.1
91.40
94.16
pmol/l
0.29
137
897
10
31
3.27
2.53
1.1
1.0
—
—
—
0
0
19
89
2.18
2.48
1.7
1.4
—
—
—
0
0
98
729
1.43
2.48
3.4
2.8
1.13
1.06
e6/l
0.09
61
420
5
8
6.30
2.37
1.0
1.1
—
—
—
0
0
132
1041
1.37
2.37
1.7
1.6
17.56
20.63
nmol/l
1.81
114
866
32
186
1.77
2.30
2.9
3.2
4.04
4.42
pmol/l
1.24
27
165
10
34
2.98
2.29
1.8
2.4
0.80
2.77
u/field
—
5
13
48
315
1.58
2.21
3.2
2.7
66.35
61.23
ml/min/173m2
0.35
20
123
10
37
2.74
2.08
1.4
1.1
—
—
—
0
0
17
83
2.09
2.03
2.2
2.5
15.49
15.56
%
—
8
39
8
26
3.11
2.02
2.3
1.2
—
—
—
0
0
5
11
4.58
1.94
1.2
1.1
—
—
—
0
0
8
27
2.99
1.94
2.3
1.2
—
—
—
0
0
6
16
3.78
1.94
1.2
1.1
—
—
—
0
0
6
16
3.78
1.94
7.0
2.3
136.33
99.44
%
—
6
16
6
16
3.78
1.94
1.3
1.3
—
—
—
0
0
305
2759
1.28
1.90
5.9
3.7
14.62
14.96
pmol/l
1.56
285
2446
6
17
3.56
1.84
1.0
1.1
10.10
9.30
ug/l
—
6
17
72
537
1.40
1.80
1.3
1.3
1.02
14.62
u/ml
3.34
30
188
7
23
3.07
1.80
1.3
1.1
2.96
1.85
mmol/l
—
7
23
31
195
1.63
1.73
1.2
1.2
53.39
114.14
iu/ml
—
7
71
5
13
3.87
1.72
1.8
1.7
43.02
77.56
ug/l
—
5
13
41
281
1.50
1.61
6.5
8.5
23.75
24.62
mmol/l
0.67
36
270
8
32
2.52
1.60
1.3
1.1
—
—
—
0
0
94
748
1.32
1.57
1.3
1.2
4.67
1.34
u/ml
0.60
22
195
62
464
1.39
1.54
1.5
1.4
—
—
—
0
0
339
3615
0.80
1.51
6.7
6.3
40.16
40.68
mmol/mol
0.50
316
3326
189
1655
1.23
1.43
4.6
4.0
34.11
39.40
ng/l
0.45
149
1267
9
41
2.22
1.37
1.0
1.3
—
—
—
0
0
355
3746
0.81
1.28
5.5
4.6
1.31
1.42
mmol/l
5.04
334
3386
10
48
2.11
1.28
2.3
3.8
—
—
—
0
0
367
3858
0.80
1.27
6.0
5.2
2.72
2.62
mmol/l
1.32
343
3492
8
35
2.31
1.27
1.0
1.0
—
—
—
0
0
9
45
2.02
1.24
1.0
1.1
—
—
—
0
0
11
56
1.99
1.23
1.0
1.3
—
—
—
0
0
399
3812
1.26
1.16
42.0
16.1
26.24
26.11
mg/l
0.02
370
3076
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
5
20
2.51
1.15
1.2
1.7
0.61
0.87
nmol/l
—
5
14
13
217
0.59
1.08
2.7
1.7
—
—
—
0
0
135
1538
0.83
1.05
4.0
4.5
20.97
21.19
%
0.05
57
763
11
190
0.57
1.04
1.7
1.5
—
—
—
0
0
106
902
1.22
1.04
1.8
1.7
609.34
5384009.41
pmol/l
0.50
89
743
212
1924
1.18
1.03
3.9
3.9
0.00
0.00
estimate
-0.00
46
335
9
48
1.89
1.01
1.0
1.1
—
—
—
0
0
361
3774
0.83
0.99
6.4
4.7
4.54
4.49
mmol/l
0.46
344
3444
5
23
2.19
0.98
1.6
1.6
0.80
1.01
g/l
—
5
23
208
1892
1.17
0.97
5.3
5.2
0.00
0.00
estimate
-0.00
49
350
221
2021
1.17
0.97
3.0
2.5
—
—
—
0
0
11
63
1.76
0.90
1.2
1.2
—
—
—
0
0
6
29
2.08
0.89
1.5
1.0
—
—
—
0
0
408
4204
0.82
0.86
56.9
23.4
218.69
240.04
e9/l
6.65
401
4091
10
57
1.77
0.84
1.1
1.1
1.68
1.54
g/l
—
10
52
17
113
1.52
0.83
1.8
1.5
269.83
267.75
ug/g
0.02
12
63
6
32
1.89
0.82
1.2
3.0
24.62
66.40
u/ml
—
6
32
409
4206
0.83
0.78
57.1
23.5
37.60
40.10
%
9.95
387
3909
409
4206
0.83
0.78
56.7
23.4
4.18
4.47
e12/l
16.34
402
4075
97
1105
0.85
0.75
2.8
3.1
0.61
0.78
ug/l
1.95
66
739
205
1894
1.14
0.74
4.0
3.8
0.00
0.00
estimate
0.50
50
374
5
25
2.01
0.73
1.0
4.2
93.20
95.68
nmol/l
—
5
25
17
117
1.47
0.72
3.4
2.6
8.17
7.93
kpa
0.28
17
112
57
474
1.23
0.72
2.0
4.4
3.58
38.74
ug/l
1.36
45
405
5
26
1.93
0.71
2.4
2.4
—
—
—
0
0
16
112
1.44
0.64
1.6
1.3
—
—
—
0
0
67
575
1.19
0.63
1.3
1.3
10.17
41.30
iu/ml
6.60
20
176
8
51
1.58
0.60
1.0
1.0
—
—
—
0
0
162
1494
1.13
0.59
4.4
4.1
—
—
—
0
0
256
2428
1.11
0.56
5.7
3.3
75.43
55.98
u/l
1.48
240
2243
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
—
—
—
0
0
179
1910
0.90
0.51
4.4
5.2
2.29
2.80
ug/l
0.40
164
1689
114
1042
1.12
0.48
4.5
4.0
0.00
0.00
estimate
-0.00
46
335
353
3633
0.90
0.48
6.5
4.2
1.46
1.29
mmol/l
3.87
334
3264
24
192
1.26
0.46
2.5
3.6
35.28
2196.38
u/ml
1.44
18
161
5
31
1.62
0.43
1.4
1.3
150.60
157.62
pmol/l
—
5
31
11
150
0.73
0.42
1.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
3.0
—
—
—
0
0
0
18
0.00
0.40
0.0
3.0
—
—
—
0
0
369
3776
0.91
0.39
6.3
4.9
5.99
6.07
mmol/l
0.78
343
3394
9
123
0.73
0.35
1.2
1.7
40.44
43.27
nmol/l
—
9
116
6
44
1.37
0.34
1.2
1.1
—
—
—
0
0
397
4039
0.91
0.33
42.7
19.0
3.97
4.01
mmol/l
1.87
391
3931
21
251
0.83
0.31
1.6
1.8
—
—
—
0
0
10
76
1.32
0.28
1.3
1.3
—
—
—
0
0
397
4030
0.92
0.27
41.9
18.9
139.03
139.65
mmol/l
4.53
391
3923
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
5
43
1.16
0.21
1.6
2.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
321.71
—
0
7
6
77
0.78
0.15
1.2
1.9
—
—
—
0
0
48
510
0.93
0.14
17.9
7.3
—
—
—
0
0
138
1342
1.04
0.12
3.8
3.8
9.42
9.15
mg/mmol
0.03
86
856
348
3445
1.04
0.11
6.0
4.5
1.93
1.98
mu/l
0.33
329
3073
10
86
1.17
0.11
1.3
1.3
1.23
0.82
nmol/l
—
10
71
108
1051
1.04
0.09
2.0
1.7
1.63
1.34
mmol/l
2.13
99
865
6
54
1.11
0.09
1.0
3.2
3.38
7.01
nmol/l
—
6
54
6
56
1.07
0.08
1.8
1.2
—
—
—
0
0
7
68
1.03
0.08
3.0
3.0
105.00
105.22
mmol/l
—
7
68
9
86
1.05
0.07
1.2
1.1
—
—
—
0
0
31
325
0.95
0.06
1.9
1.4
—
—
—
0
0
88
861
1.03
0.06
4.4
4.2
1.02
1.02
kg/l
0.06
12
128
53
538
0.98
0.01
4.9
4.7
28.20
31.72
%
2.05
46
351
40
393
1.02
0.01
1.6
1.7
1.38
1.58
%
1.39
34
336
131
1303
1.01
0.01
3.0
3.1
7.42
7.69
mmol/l
0.35
105
1068
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
23.33
—
0
7
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
12.37
—
0
6
0
6
0.00
0.00
0.0
1.3
—
8.73
—
0
6
0
8
0.00
0.00
0.0
1.1
—
110.00
—
0
8
365
3650
1.00
-0.00
33.5
14.9
76.30
76.91
ml/min/173m2
0.20
333
3030
5
49
1.02
-0.00
1.2
1.3
0.74
0.55
nmol/l
—
5
41
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.8
4.7
324.60
354.30
umol/l
—
5
43
9
92
0.98
-0.00
1.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_TNK_LYMPHOMA – Mature T/NK-cell lymphomas, hilmo
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).